424 related articles for article (PubMed ID: 23770332)
1. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
2. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.
Cadorna-Carlos J; Vidor E; Bonnet MC
Int J Infect Dis; 2012 Feb; 16(2):e110-6. PubMed ID: 22153001
[TBL] [Abstract][Full Text] [Related]
4. Fractional doses of inactivated poliovirus vaccine in Oman.
Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
[TBL] [Abstract][Full Text] [Related]
5. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.
Resik S; Tejeda A; Mach O; Sein C; Molodecky N; Jarrahian C; Saganic L; Zehrung D; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW
Vaccine; 2015 Oct; 33(43):5873-5877. PubMed ID: 26192350
[TBL] [Abstract][Full Text] [Related]
6. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.
Clarke E; Saidu Y; Adetifa JU; Adigweme I; Hydara MB; Bashorun AO; Moneke-Anyanwoke N; Umesi A; Roberts E; Cham PM; Okoye ME; Brown KE; Niedrig M; Chowdhury PR; Clemens R; Bandyopadhyay AS; Mueller J; Jeffries DJ; Kampmann B
Lancet Glob Health; 2016 Aug; 4(8):e534-47. PubMed ID: 27364568
[TBL] [Abstract][Full Text] [Related]
8. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y
J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.
Resik S; Tejeda A; Lago PM; Diaz M; Carmenates A; Sarmiento L; Alemañi N; Galindo B; Burton A; Friede M; Landaverde M; Sutter RW
J Infect Dis; 2010 May; 201(9):1344-52. PubMed ID: 20350164
[TBL] [Abstract][Full Text] [Related]
11. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial.
McAllister L; Anderson J; Werth K; Cho I; Copeland K; Le Cam Bouveret N; Plant D; Mendelman PM; Cobb DK
Lancet; 2014 Aug; 384(9944):674-81. PubMed ID: 24881803
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.
Snider CJ; Zaman K; Estivariz CF; Yunus M; Weldon WC; Wannemuehler KA; Oberste MS; Pallansch MA; Wassilak SG; Bari TIA; Anand A
Lancet; 2019 Jun; 393(10191):2624-2634. PubMed ID: 31104832
[TBL] [Abstract][Full Text] [Related]
13. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
[TBL] [Abstract][Full Text] [Related]
14. Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
Jarrahian C; Rein-Weston A; Saxon G; Creelman B; Kachmarik G; Anand A; Zehrung D
Vaccine; 2017 Mar; 35(14):1789-1796. PubMed ID: 28189403
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
Gorse GJ; Falsey AR; Johnson CM; Morrison D; Fried DL; Ervin JE; Greenberg DP; Ozol-Godfrey A; Landolfi V; Tsang PH
Vaccine; 2013 Dec; 31(50):6034-40. PubMed ID: 24055306
[TBL] [Abstract][Full Text] [Related]
16. Priming after a fractional dose of inactivated poliovirus vaccine.
Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB
N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
[TBL] [Abstract][Full Text] [Related]
18. [Reactogenicity associated to the intradermally administered inactivated poliovirus vaccine with a needle-free injector].
Tejeda Fuentes A; de Armas López J; Silva Sosa M; Alemañy Bueno N; Carmenate García A; García González G; Díaz González M; Resik Aguirre S
Rev Cubana Med Trop; 2011; 63(1):38-43. PubMed ID: 23437535
[TBL] [Abstract][Full Text] [Related]
19. Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose.
Roozen GVT; Prins MLM; Prins C; Janse JJ; de Gruyter HLM; Pothast CR; Huisman W; Koopman JPR; Lamers OAC; Kuijer M; Myeni SK; van Binnendijk RS; Hartog GD; Heemskerk MHM; Jochems SP; Feltkamp MCW; Kikkert M; Rosendaal FR; Roestenberg M; Visser LG; Roukens AHE
Clin Microbiol Infect; 2024 Jul; 30(7):930-936. PubMed ID: 38552793
[TBL] [Abstract][Full Text] [Related]
20. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
